Teva Pharmaceutical Industries Limited Stock NYSE
Stocks
TEVA
US8816242098
Pharmaceuticals
OTC Markets Traded| Market Cap | 47.89B 42.77B 39.79B 36.19B 68.34B 4,635B 68.63B 479B 188B 2,363B 180B 176B 7,584B | P/E 2026 * |
55.1x | P/E 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 59.26B 52.93B 49.23B 44.78B 84.55B 5,735B 84.92B 593B 232B 2,924B 223B 218B 9,383B | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 3.28x |
| Free-Float |
91.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +2.04% | ||
| 1 week | +0.65% | ||
| Current month | +2.88% | ||
| 1 month | +0.87% | ||
| 3 months | +12.70% | ||
| 6 months | +25.90% | ||
| Current year | +18.84% |
| 1 week | 36.06 |  | 37.11 |
| 1 month | 35.42 | | 38.37 |
| Current year | 27.93 | | 38.37 |
| 1 year | 18.21 | | 38.37 |
| 3 years | 8.06 | | 38.37 |
| 5 years | 6.78 | | 38.37 |
| 10 years | 6.07 | | 51.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | 52 | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 65 | 2015-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/5/26 | Sell | Director | -17 | 0.0000% | ||
| 8/3/26 | Exercice | Chief Technology Officer | 131,066 | 0.0112% | ||
| 8/3/26 | Exercice | Head of Human Resources | 38,481 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +0.65% | - | - | 47.89B | |
| +0.83% | +3.19% | +41.49% | +94.83% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +67.40% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.13% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.73% | 359B | |
| +1.45% | +3.50% | +23.29% | +40.84% | 344B | |
| +1.17% | +2.37% | +13.47% | +32.81% | 272B | |
| +0.89% | +1.08% | -6.13% | +9.63% | 246B | |
| +1.82% | +2.94% | +42.99% | +46.29% | 224B | |
| +2.77% | +4.44% | +29.01% | +96.43% | 187B | |
| Average | +1.66% | +2.86% | +30.05% | +57.12% | 422.63B | |
| Weighted average by Cap. | +1.48% | +2.93% | +33.36% | +66.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.66B 14.88B 13.84B 12.59B 23.77B 1,612B 23.87B 167B 65.26B 822B 62.55B 61.18B 2,637B | 17.24B 15.4B 14.33B 13.03B 24.6B 1,669B 24.71B 172B 67.56B 851B 64.76B 63.34B 2,730B |
| Net income | 1.19B 1.07B 992M 902M 1.7B 116B 1.71B 11.93B 4.68B 58.89B 4.48B 4.38B 189B | 2.44B 2.17B 2.02B 1.84B 3.47B 236B 3.49B 24.35B 9.54B 120B 9.15B 8.95B 386B |
| Net Debt | 11.37B 10.15B 9.44B 8.59B 16.22B 1,100B 16.29B 114B 44.53B 561B 42.68B 41.75B 1,800B | 8.71B 7.77B 7.23B 6.58B 12.42B 843B 12.47B 87.05B 34.11B 430B 32.69B 31.98B 1,378B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
